Corbion NV
AEX:CRBN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
16.26
23.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
CRBN
stock under the Base Case scenario is
30.43
EUR.
Compared to the current market price of 18.67 EUR,
Corbion NV
is
Undervalued by 39%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Corbion NV.
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
|
| CH |
|
Sika AG
F:SIKA
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
|
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Corbion NV
Balance Sheet Decomposition
Corbion NV
| Current Assets | 514.2m |
| Cash & Short-Term Investments | 40.1m |
| Receivables | 214.8m |
| Other Current Assets | 259.3m |
| Non-Current Assets | 939.3m |
| Long-Term Investments | 111.8m |
| PP&E | 704.8m |
| Intangibles | 92.2m |
| Other Non-Current Assets | 30.5m |
| Current Liabilities | 423.3m |
| Accounts Payable | 103.5m |
| Other Current Liabilities | 319.8m |
| Non-Current Liabilities | 304m |
| Long-Term Debt | 281.9m |
| Other Non-Current Liabilities | 22.1m |
Free Cash Flow Analysis
Corbion NV
| EUR | |
| Free Cash Flow | EUR |
Earnings Waterfall
Corbion NV
|
Revenue
|
1.3B
EUR
|
|
Cost of Revenue
|
-958.2m
EUR
|
|
Gross Profit
|
338.4m
EUR
|
|
Operating Expenses
|
-225.9m
EUR
|
|
Operating Income
|
112.5m
EUR
|
|
Other Expenses
|
-46.3m
EUR
|
|
Net Income
|
66.2m
EUR
|
CRBN Profitability Score
Profitability Due Diligence
Corbion NV's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Corbion NV's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
CRBN Solvency Score
Solvency Due Diligence
Corbion NV's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Score
Corbion NV's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRBN Price Targets Summary
Corbion NV
According to Wall Street analysts, the average 1-year price target for
CRBN
is 23.92 EUR
with a low forecast of 17.17 EUR and a high forecast of 32.55 EUR.
Dividends
Current shareholder yield for
CRBN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CRBN
stock under the Base Case scenario is
30.43
EUR.
Compared to the current market price of 18.67 EUR,
Corbion NV
is
Undervalued by 39%.